BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 23176003)

  • 21. [Nuclear atypia and epigenetic change].
    Ichimura T; Ito T
    Tanpakushitsu Kakusan Koso; 2006 Nov; 51(14 Suppl):2049-51. PubMed ID: 17471907
    [No Abstract]   [Full Text] [Related]  

  • 22. Epigenetic methylation and expression of caspase 8 and survivin in hepatocellular carcinoma.
    Cho S; Lee JH; Cho SB; Yoon KW; Park SY; Lee WS; Park CH; Joo YE; Kim HS; Choi SK; Rew JS
    Pathol Int; 2010 Mar; 60(3):203-11. PubMed ID: 20403046
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Promoter methylation status of multiple genes in uveal melanoma.
    Merhavi E; Cohen Y; Avraham BC; Frenkel S; Chowers I; Pe'er J; Goldenberg-Cohen N
    Invest Ophthalmol Vis Sci; 2007 Oct; 48(10):4403-6. PubMed ID: 17898258
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Master and servant: epigenetic deregulations as a cause and a consequence of cancer].
    Laget S; Defossez PA
    Med Sci (Paris); 2008; 24(8-9):725-30. PubMed ID: 18789219
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Well-defined melanoma antigens as progression markers for melanoma: insights into differential expression and host response based on stage.
    Hodi FS
    Clin Cancer Res; 2006 Feb; 12(3 Pt 1):673-8. PubMed ID: 16467076
    [No Abstract]   [Full Text] [Related]  

  • 26. Detection of aberrant methylation of four genes in plasma DNA for the detection of breast cancer.
    Hoque MO; Feng Q; Toure P; Dem A; Critchlow CW; Hawes SE; Wood T; Jeronimo C; Rosenbaum E; Stern J; Yu M; Trink B; Kiviat NB; Sidransky D
    J Clin Oncol; 2006 Sep; 24(26):4262-9. PubMed ID: 16908936
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Genetic and epigenetic alteration in cancer].
    Inoue J; Inazawa J
    Tanpakushitsu Kakusan Koso; 2006 Nov; 51(14 Suppl):2256-62. PubMed ID: 17471950
    [No Abstract]   [Full Text] [Related]  

  • 28. [Novel methylation and expression markers associated with breast cancer].
    Kuznetsova EB; Kekeeva TV; Larin SS; Zemliakova VV; Babenko OV; Nemtsova MV; Zaletaev DV; Strel'nikov VV
    Mol Biol (Mosk); 2007; 41(4):624-33. PubMed ID: 17936981
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Promoter hypermethylation of TMS1, BRCA1, ERalpha and PRB in serum and tumor DNA of invasive ductal breast carcinoma patients.
    Mirza S; Sharma G; Prasad CP; Parshad R; Srivastava A; Gupta SD; Ralhan R
    Life Sci; 2007 Jul; 81(4):280-7. PubMed ID: 17599361
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epigenetic inactivation of deleted in lung and esophageal cancer 1 gene by promoter methylation in gastric and colorectal adenocarcinoma.
    Zhang Y; Ye X; Geng J; Chen L
    Hepatogastroenterology; 2010; 57(104):1614-9. PubMed ID: 21443130
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Aberrant DNA methylation in cutaneous malignancies.
    van Doorn R; Gruis NA; Willemze R; van der Velden PA; Tensen CP
    Semin Oncol; 2005 Oct; 32(5):479-87. PubMed ID: 16210089
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epigenetic analysis in the search for tumor suppressor genes.
    Han ZG
    Epigenomics; 2010 Aug; 2(4):489-93. PubMed ID: 22121966
    [No Abstract]   [Full Text] [Related]  

  • 33. Epigenetic markers of early tumor development.
    Dumitrescu RG
    Methods Mol Biol; 2012; 863():3-14. PubMed ID: 22359284
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Epigenetic alterations in cancer].
    Toyota M; Suzuki H; Imai K; Shinomura Y
    Tanpakushitsu Kakusan Koso; 2006 Nov; 51(14 Suppl):2043-8. PubMed ID: 17471906
    [No Abstract]   [Full Text] [Related]  

  • 35. Epigenetic deregulation across chromosome 2q14.2 differentiates normal from prostate cancer and provides a regional panel of novel DNA methylation cancer biomarkers.
    Devaney J; Stirzaker C; Qu W; Song JZ; Statham AL; Patterson KI; Horvath LG; Tabor B; Coolen MW; Hulf T; Kench JG; Henshall SM; Pe Benito R; Haynes AM; Mayor R; Peinado MA; Sutherland RL; Clark SJ
    Cancer Epidemiol Biomarkers Prev; 2011 Jan; 20(1):148-59. PubMed ID: 21098650
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quantitative, spatial resolution of the epigenetic field effect in prostate cancer.
    Mehrotra J; Varde S; Wang H; Chiu H; Vargo J; Gray K; Nagle RB; Neri JR; Mazumder A
    Prostate; 2008 Feb; 68(2):152-60. PubMed ID: 18058812
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epigenetic alterations in gastric carcinogenesis.
    Choi IS; Wu TT
    Cell Res; 2005 Apr; 15(4):247-54. PubMed ID: 15857579
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epigenetic regulation of telomeres in human cancer.
    Vera E; Canela A; Fraga MF; Esteller M; Blasco MA
    Oncogene; 2008 Nov; 27(54):6817-33. PubMed ID: 18762811
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Colorectal cancer: a model for epigenetic tumorigenesis.
    Wong JJ; Hawkins NJ; Ward RL
    Gut; 2007 Jan; 56(1):140-8. PubMed ID: 16840508
    [No Abstract]   [Full Text] [Related]  

  • 40. Epigenetic regulation of microRNA-375 and its role in melanoma development in humans.
    Mazar J; DeBlasio D; Govindarajan SS; Zhang S; Perera RJ
    FEBS Lett; 2011 Aug; 585(15):2467-76. PubMed ID: 21723283
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.